Desai Nisheeth C, Khasiya Ashvinkumar G, Jadeja Dharmpalsinh J, Monapara Jahnvi D, Jethawa Aratiba M, Dave Bharti P, Sivan Sree Kanth, Manga Vijjulatha, Mhaske Pravin C, Chaudhary Doongar R
Division of Medicinal Chemistry, Department of Chemistry, Mahatma Gandhi Campus, Maharaja Krishnakumarsinhji Bhavnagar University, Bhavnagar, Gujarat 364002, India.
School of Science, Indrashil University, Rajpur, Gujarat 382 740, India.
ACS Omega. 2023 Oct 6;8(41):37781-37797. doi: 10.1021/acsomega.3c01722. eCollection 2023 Oct 17.
Multidrug-resistant fungal infections have become much more common in recent years, especially in immune-compromised patients. Therefore, researchers and pharmaceutical professionals have focused on the development of novel antifungal agents that can tackle the problem of resistance. In continuation to this, a novel series of pyrazole-bearing pyrido[2,3-]pyrimidine-2,4(1,3)-dione derivatives (-) have been developed. These compounds have been screened against , , and . The synthesized compounds were characterized by well-known spectroscopic techniques, i.e., IR, H NMR, C NMR, and mass spectrometry. antifungal results revealed that compound showed activity against having MIC value of 200 μg/mL. To know the plausible mode of action, the active derivatives were screened for anti-biofilm and ergosterol biosynthesis inhibition activities. The compounds , , , and showed greater ergosterol biosynthesis inhibition than the control DMSO. To comprehend how molecules interact with the receptor, studies of molecular docking of and have been performed on the homology-modeled protein of β-tubulin. The molecular docking revealed that the active compounds , , , , and interacting with the active site amino acid of sterol 14-alpha demethylase (PDB ID: 5v5z) indicate one of the possible modes of action of ergosterol inhibition activity. The synthesized compounds , , , , , , , and inhibited biofilm formation and possessed the potential for anti-biofilm activity. DFT-based quantum mechanical calculations were carried out to optimize, predict, and compare the vibration modes of the molecule .
近年来,多重耐药真菌感染变得更加常见,尤其是在免疫功能低下的患者中。因此,研究人员和制药专业人员专注于开发能够解决耐药问题的新型抗真菌剂。在此基础上,已经开发了一系列新型的含吡唑的吡啶并[2,3 - ]嘧啶 - 2,4(1,3) - 二酮衍生物(-)。这些化合物已针对、和进行了筛选。合成的化合物通过红外光谱、氢核磁共振、碳核磁共振和质谱等知名光谱技术进行了表征。抗真菌结果表明,化合物对具有200μg/mL的最低抑菌浓度(MIC)值。为了了解可能的作用方式,对活性衍生物进行了抗生物膜和麦角甾醇生物合成抑制活性的筛选。化合物、、、和显示出比对照二甲基亚砜(DMSO)更强的麦角甾醇生物合成抑制作用。为了理解分子如何与受体相互作用,已经对β - 微管蛋白的同源建模蛋白进行了和的分子对接研究。分子对接表明,活性化合物、、、、和与甾醇14 - α脱甲基酶(PDB ID:5v5z)的活性位点氨基酸相互作用,这表明了麦角甾醇抑制活性的一种可能作用方式。合成的化合物、、、、、、、和抑制生物膜形成,并具有抗生物膜活性的潜力。进行了基于密度泛函理论(DFT)的量子力学计算,以优化、预测和比较分子的振动模式。